The Congress will combine the best of our organizations’ popular research meetings, including NAF’s Ataxia Investigators Meeting (AIM) and the International Ataxia Research Conference (IARC), co-led by FARA, Ataxia UK, GoFAR, and other partner organizations. ICAR will cover aspects of cerebellar function, neurodegeneration, and treatment of Ataxias, and will provide ample opportunities to network, as well as interact with Ataxia patients and families. Leading the scientific steering committee are Co-Chairs Stefan-M. Pulst, M.D., Dr. med., Professor and Chair of the Department of Neurology at the University of Utah, USA, and Massimo Pandolfo, M.D., F.A.A.N., F.E.A.N., Professor of Neurology at Université Libre de Bruxelles, Hôpital Erasme, Belgium.
“I am extremely excited to co-chair this new Ataxia meeting that will bring together clinicians and scientists from around the world and at all stages of their careers”, says Professor Pulst. “The congress will cover diverse topics ranging from cerebellar function and imaging to novel therapies in sporadic and genetic Ataxias”.
As research on Ataxia continues to advance and pharmaceutical interest grows, international collaboration among patient advocacy groups, scientific and clinical researchers, and pharmaceutical companies is more critical than ever.
Professor Pandolfo states, “It is a great privilege to co-chair ICAR 2022, I expect exciting new developments in diagnosis, pathophysiology and particularly treatment. The meeting will be designed in order to maximize interaction, develop existing collaborations and prompt new ones.”
NAF, FARA and Ataxia UK are thrilled to be working together to host what will undoubtedly be hailed as the conference to attend in 2022! ICAR information will be available at ataxiacongress.org